Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common stock, par value $0.00001
-
Shares outstanding
-
1,126,994
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
43,890
-
Shares change
-
+39,395
-
Total reported value, excl. options
-
$155,808
-
Value change
-
+$139,805
-
Number of buys
-
4
-
Number of sells
-
-2
-
Price
-
$3.52
Significant Holders of Shuttle Pharmaceuticals Holdings, Inc. - Common stock, par value $0.00001 (SHPH) as of Q3 2025
7 filings reported holding SHPH - Shuttle Pharmaceuticals Holdings, Inc. - Common stock, par value $0.00001 as of Q3 2025.
Shuttle Pharmaceuticals Holdings, Inc. - Common stock, par value $0.00001 (SHPH) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,890 shares
of 1,126,994 outstanding shares and own 3.89% of the company stock.
Largest 7 shareholders include DRW Securities, LLC (42,830 shares), Tower Research Capital LLC (TRC) (1,015 shares), MORGAN STANLEY (27 shares), UBS Group AG (8 shares), BANK OF AMERICA CORP /DE/ (8 shares), Federation des caisses Desjardins du Quebec (2 shares), and RAYMOND JAMES FINANCIAL INC (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.